Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. 

Biotechnology

Arch Therapeutics

Arch Therapeutics' headquarters in Framingham, MA, United States

Terrence W. Norchi

Chirag B. Shah

Richard E. Davis

Michael Abrams

Elaine Whitmore

Punit Dhillon

Avtar Dhillon

Larry Hicks

John Richards

Shri Parikh

William T. Denman

Rutledge Ellis-Behnke

Daniel Kapp

Roger Gregory

William G. Austen

Steven A. Kates

Steve Schwaitzberg

James Sulat

The Advisory Team at Arch Therapeutics plays a crucial role in guiding the company's strategy and operations across various domains, including regulatory compliance, business development, and clinical expertise. Comprising industry veterans and specialists in hemostasis, wound care, and surgical practices, this team provides strategic insights and recommendations to enhance product development, navigate regulatory pathways, and ensure the efficacy and safety of innovative wound management solutions.

Advisory Team

The Leadership Team at Arch Therapeutics is responsible for guiding the strategic direction and operational oversight of the company. This team, comprised of key executives such as the CEO, CFO, and VPs of R&D and Engineering, collaborates to drive innovation in biotechnology, ensure financial stability, and foster a culture of excellence in the development of advanced hemostatic and sealing solutions for surgical and trauma care.

Leadership Team

Arch Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Arch Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies